Today's News | Note: News feeds may no longer be available for the articles on this page.

Spectrum says FDA extends review date of cancer drug 10:01 AM 2/23/2009
Reuters - USA
The US FDA extended the review date of Spectrum Pharmaceuticals Inc's experimental cancer drug Zevalin by three months. ...

ThromboGenics in new trials for anti-blood clot drug 5:35 AM 2/23/2009
Reuters - USA
ThromboGenics entered the second phase of trials for its anti-blood clot treatment TB-402 developed in partnership with BioInvent. ...

Merck girds to battle Teva's generic Singulair 3:55 PM 2/22/2009
Reuters - USA
Merck & Co is expected to fight efforts by Teva Pharmaceutical Industries to introduce a generic of Singulair. It's Merck's biggest productat at $4 billion-a-year. ...

Cell Therapeutics sells stake in cancer drug 6:21 AM 2/21/2009
Forbes - NY,USA
Cell Therapeutics Inc is exercising its option to sell its half of a stake in the cancer drug Zevalin to Spectrum Pharmaceuticals Inc for $18 million. ...

Schering, Takeda Unit Sue Teva Over Snake-Drug Patent 5:19 AM 2/20/2009
Bloomberg - USA
Schering and Takeda Pharmaceutical’s Millennium subsidiary are accusing Teva Pharmaceutical Industries of infringing US patents for their rattlesnake venom derived Integrilin anti-clotting agent. ...

Johnson & Johnson Is Sued by US in Heart-Drug Cases 3:33 AM 2/20/2009
Bloomberg - USA
The US joined two whistleblower lawsuits accusing a unit of Johnson & Johnson of marketing heart drug Natrecor for unauthorized use which cost Medicare a ton of money. ...

Watson The Great 2:12 AM 2/20/2009
Forbes - NY,USA
Watson Pharmaceuticals expects to bring three new urology products to market in 2009. It plans to expand into Europe with branded and generic drugs. Recently approved Gelnique for overactive bladders and Rapalfo for benign prostatic hyperplasia could be big. ...

FDA says 3 deaths associated with Genentech drug 11:05 AM 2/19/2009
The Associated Press
The US FDA has confirmed three deaths from progressive multifocal leukoencephalopathy (PML). PML causes brain swelling and is usually fatal. The patients had been taking Genentech's once-a-week injection Raptiva for psoriasis. ...

Nymox Provides Update On Pivotal Phase 3 Trials for BPH Drug 5:43 PM 2/18/2009
MSNBC - USA
Nymox Pharmaceutical Corp recently concluded a meeting with the US FDA concerning the Phase 3 program for NX-1207. It's the company's investigational drug for benign prostatic hyperplasia (BPH). ...

Doctors test new way to regulate warfarin dose 3:33 PM 2/18/2009
Reuters - USA
Better prediction of the proper dose of the blood thinner warfarin could help prevent dangerous blood clots and serious bleeding. ...

Amgen says FDA accepts bone loss drug application 2:22 PM 2/18/2009
Forbes - NY,USA
The US FDA accepted Amgen Inc's application for the bone loss drug candidate denosumab. The agency should make a ruling around mid October. ...

Teva invests $10.5 mln in diabetes drug developer 1:23 PM 2/18/2009
Reuters - USA
Andromeda Biotech is developing a treatment for juvenile diabetes. Teva Pharmaceutical Industries exercised an option to invest $10.5 million raising its stake to 10 percent. ...

GTx's bone fracture drug under FDA review 7:51 AM 2/18/2009
Forbes - NY,USA
The biopharmaceutical company GTx Inc said that the US FDA is reviewing its application for the drug candidate toremifene for the prevention of bone fractures in men with prostate cancer on androgen deprivation therapy. ...

Nausea Drug May Treat Withdrawal From Addiction, Study Shows 5:18 AM 2/18/2009
Bloomberg - USA
GlaxoSmithKline's Zofran (ondansetron) is approved to treat nausea and vomiting. A study suggests it reduces symptoms of withdrawal from morphine, codeine, heroin, oxyContin and related pain medications. ...

Menopause drug Livial ups breast cancer return risk 4:18 PM 2/17/2009
Reuters - USA
Schering Plough Corp's synthetic hormone Livial (tibolone) makes it significantly more likely a woman's breast cancer will return. The hormone is an alternative to hormone replacement therapy and marketed mostly in Europe. ...

<- Day Earlier | Today's News